The Use of Prophylaxis Antibiotics to Prevent Acute Pancreatitis Complications: Meta-Analysis of Clinical Trials

Authors

  • Dwita Nitoya Esterini Faculty of Medicine, Christian University of Indonesia, Jakarta
  • Kirsten Putriani Hartman Faculty of Medicine, Christian University of Indonesia, Jakarta
  • Joue Abraham Trixie Faculty of Medicine, Christian University of Indonesia, Jakarta
  • Yessi Setianegari Faculty of Medicine, Christian University of Indonesia, Jakarta
  • Kurniyanto Kurniyanto Department of Internal Medicine, Faculty of Medicine, Christian University of Indonesia, Jakarta

DOI:

https://doi.org/10.24871/2232021196-202

Keywords:

acute pancreatitis, antibiotic prophylaxis, clinical trial, mortality

Abstract

Background: Acute pancreatitis (AP) is an inflammation of the pancreas, a serious emergency with no definitive treatment. It may progress to infected necrosis, non-pancreatitis infection, also death that may occur within the first 1 to 2 weeks. The use of prophylactic antibiotics in AP to prevent complications remains a controversy. The objective of this meta-analysis is to assess the benefit of prophylaxis antibiotics administration to prevent the complication.

Method: Trials were identified by searching the medical database. Literature range is within the year 1975 to 2021.  Review Manager 5.4.1 was used to analyse data extraction and risk of bias of included studies were elaborated. Risk ratio (RR) was calculated with 95% confidence interval (CI). P < 0.05 was considered significant.

Results: Twenty trials with a total of 1.287 patients of AP were analysed; 646 patients treated with antibiotic prophylaxis and 641 patients treated with placebo. Prophylaxis antibiotics were found to have significant difference between the two groups. The administration of prophylaxis antibiotics lower the risk of non-pancreatic infections (RR = 0.77; 95% CI: 0.62–0.95; p < 0.05) and infected pancreatic necrosis (RR = 0.74; 95% CI: 0.58-0.94; p < 0.05). Meanwhile, prophylaxis antibiotics were found to be insignificant to lower the risk of mortality (RR = 0.75; 95% CI: 0.54-1.03; p > 0.05). 

Conclusion: Prophylaxis antibiotics lower the risk of non-pancreatic infections and infected pancreatic necrosis, but did not lower the risk of mortality.

Downloads

Published

2022-01-05

How to Cite

Esterini, D. N., Hartman, K. P., Trixie, J. A., Setianegari, Y., & Kurniyanto, K. (2022). The Use of Prophylaxis Antibiotics to Prevent Acute Pancreatitis Complications: Meta-Analysis of Clinical Trials. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 22(3), 196–202. https://doi.org/10.24871/2232021196-202

Issue

Vol. 22 No. 3 (2021): VOLUME 22, NUMBER 3, December 2021

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).